Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
The Vita Coco Company, Inc. filed an automatic shelf registration on Form S-3 to permit the resale, from time to time, of 467,071 shares of common stock by former Copra Inc. shareholders. These shares were issued as part of Vita Coco’s acquisition of Copra, which closed on July 22, 2026.
The filing is solely for selling stockholders’ benefit; Vita Coco is not selling shares and will receive no proceeds from these resales. The Copra merger consideration totaled $175 million, consisting of 467,071 Vita Coco shares plus $140,000,210.59 in cash, with additional contingent earnout payments between $45 million and $100 million based on Copra’s 2028 (or accelerated 2027) gross profit, payable in cash, Vita Coco stock, or both.
Vita Coco notes it is a well-known seasoned issuer using a shelf process, and its common stock trades on Nasdaq under “COCO,” last reported at $74.45 per share on July 22, 2026. The company describes its asset-light coconut water and plant-based beverage business and confirms Copra now operates as a wholly owned subsidiary.
The Vita Coco Company, Inc. reported strong growth for the three and six months ended June 30, 2026, with net sales of $216,153 and $395,918 (amounts in thousands), up 28.1% and 32.1% from 2025. Growth was driven by double‑digit volume and pricing gains in Vita Coco coconut water and Private Label across both Americas and International segments.
Gross profit rose to $105,311 and $177,124 (thousands), with gross margin expanding to 48.7% and 44.7%. A key factor was approximately $15,600 of U.S. tariff refunds recognized as a reduction of cost of goods sold, alongside lower ocean freight and favorable pricing, partially offset by higher domestic logistics costs. SG&A increased to $42,172 (thousands) as the company invested in people, marketing, and distribution, yet operating income still more than doubled to $63,139 (thousands).
Net income reached $49,451 and $79,925 (thousands), with diluted EPS of $0.82 and $1.32. Operating cash flow improved sharply to $96,529 (thousands), lifting cash and equivalents to $278,640 (thousands) while the $60,000 Credit Facility remained undrawn. After quarter‑end, the board expanded the share repurchase authorization to $105,000 (thousands) and the company completed the acquisition of Copra Inc., a Thai coconut water producer, funded with $140,000 (thousands) of cash, $35,000 (thousands) in common stock, and potential 2029 earn‑out payments.
The Vita Coco Company reported strong results for the quarter ended June 30, 2026. Net sales were $216.2 million, up 28% from $168.8 million, driven by case-equivalent volume growth in Vita Coco Coconut Water and Private Label plus higher net pricing. Gross profit rose to $105.3 million and consolidated gross margin improved to 48.7% of net sales from 36.3%, helped by tariff refunds and lower freight and finished goods costs.
Net income was $49.5 million, or $0.82 per diluted share, compared with $22.9 million, or $0.38 per diluted share, a year earlier. Non-GAAP Adjusted EBITDA was $67.2 million, more than double the prior-year $29.2 million. Year-to-date net sales were $395.9 million and net income $79.9 million.
The company ended June 30, 2026 with $278.6 million in cash and cash equivalents and no debt$44 million of common stock under its buyback program and, with a new $40 million authorization approved July 21, 2026, has total authorized repurchases of $105 million. Full-year 2026 guidance was raised to net sales of $790–$805 million, gross margin of about 40%, and Adjusted EBITDA of $154–$161 million. Vita Coco also disclosed the acquisition of Copra, Inc., a producer of super-premium Thai Nam Hom coconut water.
The Vita Coco Company, Inc. completed the acquisition of Copra Inc., a producer of super-premium Thai Nam Hom coconut water, on July 22, 2026. Closing consideration totaled $175 million, composed of 467,071 Vita Coco shares and $140,000,210.59 in cash, with Copra shareholders also eligible for an additional earnout.
The aggregate earnout ranges from $45 million to $100 million based on Copra’s 2028 gross profit and will be paid in 2029 in cash, Vita Coco stock, or both, with at least 24% in cash. Copra expects full-year 2026 net sales above $100 million and has delivered a 48% net sales CAGR over the past three years.
Stock consideration was issued in a private placement, with Copra holders capped at 19.99% of Vita Coco’s pre-deal shares absent stockholder approval and granted registration rights for resale. Vita Coco expects the transaction to be accretive to its Adjusted EBITDA margins while maintaining mid-teens branded net sales growth and high-teens Adjusted EBITDA margin targets.
Wasatch Advisors filed an amended ownership report for Vita Coco Company, Inc., stating beneficial ownership of 2,255,360 shares of common stock, representing 3.9% of the class. Wasatch reports sole voting power over 1,542,909 shares and sole dispositive power over 2,255,360 shares, with no shared voting or dispositive power.
The filer indicates that it holds 5 percent or less of Vita Coco’s outstanding common stock. The report is signed by Mike Yeates, CEO of Wasatch Advisors.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $82.916 per share, executed under a pre-arranged Rule 10b5-1 trading plan. After this sale, he holds 580,296 common shares directly, plus a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
THE CHARLES SCHWAB CORPORATION reported proposed resale activity for Common Stock and discloses recent sales by an affiliate. The filing lists two past transactions by Kenneth Sadowsky: 3,900 shares sold on 04/15/2026 for $190,835 and 3,900 shares sold on 05/20/2026 for $302,150.
Vita Coco Company, Inc. director Ira Liran reported two open-market sales of common stock on June 12, 2026. One sale was 73,842 shares at a weighted average price of $80.322 per share, with trades ranging from $77.40 to $81.42. The other was 74,232 shares at a weighted average price of $80.292, within the same price range.
The filing notes these transactions were executed under a pre-arranged Rule 10b5-1 trading plan. After the sales, Liran’s reported holdings total 402,579 shares held indirectly through family trusts and 309,871 shares held directly, leaving him with about 712,450 shares overall.
Vita Coco Company, Inc. director Ira Liran reported selling 191,926 shares of Common Stock in open-market transactions. The shares were sold at a weighted average price of about $79.14 per share under a Rule 10b5-1 trading plan. After these trades, he holds 384,103 shares directly and 476,421 shares indirectly through the Ira Liran 2012 Family Trust and the Ira Liran Revocable Trust.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an option-related share sale. He exercised stock options to acquire a total of 30,000 shares of common stock at an exercise price of $10.178 per share, then sold 30,000 shares at $80.00 per share in an open-market transaction.
The filing states that the stock sales were made under a pre-arranged Rule 10b5-1 trading plan. After these transactions, Burth directly holds 57,910 shares of Vita Coco common stock and retains multiple non-qualified stock option awards with various exercise prices and expiration dates.